May 12, 2022
SoftVue Research Tops Journal of Breast Imaging Most Read List
It is a proud moment for Delphinus and our amazing research team who contributed to

Read More
February 17, 2022
AuntMinnie.com launches revamped Imaging Leaders Community with support from Delphinus Medical Technologies Inc.
AuntMinnie.com launches revamped Imaging Leaders Community with support from Delphinus Medical Technologies Inc. Radiology portal

Read More
SoftVue™ 3D Whole Breast Ultrasound Tomography System (SoftVue™)
October 12, 2021
Delphinus Receives FDA Approval for its SoftVue 3D Whole Breast Ultrasound Tomography System
Device Indicated for Screening Women with Dense Breasts as Adjunct to Digital Mammography NOVI, Michigan

Read More
March 10, 2020
Study Finds Potential of Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment
Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology, has announced that results

Read More
July 31, 2019
Rachel Brem, M.D. Appointed to Delphinus Board of Directors
Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology, announced today that Rachel

Read More
July 27, 2018
SoftVue gains additional media attention
Our SoftVue research teams at SouthCoast Health Imaging in Savannah, GA and Mount Sinai Medical

Read More
February 9, 2018
SoftVue™ Project Launch Gets National Media Attention
The SoftVue™ Discover Breast Ultrasound Prospective Case Collection project launched in July last year and

Read More
November 14, 2017
Delphinus Hosted Dense Breast Subject Experts at RSNA 2017
  Nancy Cappello, PhD, founder of You Dense, Inc., and Are You Dense Advocacy, Inc.,

Read More
October 25, 2017
Delphinus Co-Founder Receives Healthcare Professional of the Year Award
Each year the Rochester Regional Chamber of Commerce hosts the Sunrise Pinnacle Awards Ceremony to

Read More
September 6, 2017
First Patient Enrolled in Pivotal Arm of the SoftVue Clinical Project
Pictured from left to right: Mark Forchette, Delphinus CEO, Mary Yamashita, MD, National Principal Investigator

Read More